FDA and EMA accept regulatory submissions for UCB’s bimekizumab

 UCB is seeking approval for treatment in moderate-to-severe plaque psoriasis

Read on PharmaTimes

NHS COVID-19 app launches in England and Wales

App will automatically alert users when they come into close contact with someone with the virus

Read on PharmaTimes

Digital tech has health benefits for dementia patients, project finds

 The Leeds Dementia Pathfinder project supported patients and carers with tech devices

Read on PharmaTimes

Owlstone Medical’s breath biopsy test improves detection of liver disease

 Study detected Nonalcoholic Fatty Liver Disease and Nonalcoholic steatohepatitis

Read on PharmaTimes

Vertex, CRISPR Therapeutics’ sickle cell gene therapy wins PRIME designation

European Medicines Agency grants designation based on phase I/II data

Read on PharmaTimes

1 2 3

Top of page

Industry News

Insights from project could potentially improve precision medicine use for paediatric AML.
Read More >

More Stories

News

Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us